En esta página
01IRD precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
IRD Opus Genetics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ 10-K/10-Q Ago 6, 2026
$3,47
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,70mínimo 52 semanas
$7,07máximo 52 semanas
Capitalización Bursátil (MRQ)
$287M
P/E (TTM)
-2.6
BPA (TTM)
$-1.33
Ingresos (TTM)
$10M
tus insignias
Rango 52S
$2–$7
Calificación del Analista
BUY
Precio Objetivo
$13
P/E
-2.6
ROE
-4796.5%
Margen de Beneficio Neto
-1091.8%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
IRD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.47
Capitalización Bursátil (MRQ)
$287M
P/E (TTM)
-2.6
BPA (TTM)
$-1.33
Ingresos (TTM)
$10M
ROE (TTM)
-4796.5%
Deuda/Capital
0.1
Rango 52S
$2–$7
IRD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 6 de noviembre de 2020 | 1-for-4 | Inversa |
| 12 de abril de 2019 | 1-for-12 | Inversa |
| 5 de mayo de 2017 | 1-for-10 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$14M2020-12-31 → 2025-12-31
BPA$-0.802020-12-31 → 2025-12-31
Flujo de caja libre·2020-12-31 → 2020-12-31
Margen neto-1091.8%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | IRD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -2.6promedio 5A ≈-1.3 | ≈-1.3 | · | · | |
| P/S (TTM) | 29.1promedio 5A ≈27.7 | ≈27.7 | 34.5 | Valor razonable | |
| P/C (MRQ) | -22.1promedio 5A ≈4.2 | ≈4.2 | · | · | |
| EV / EBITDA | -5.3 | · | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -7.0promedio 5A ≈-13.8 | ≈-13.8 | · | · | |
| EV / Revenue (EV / Ingresos) | 14.4 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 16.1promedio 5A ≈4.2 | ≈4.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | IRD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -513.5%promedio 5A ≈-940.2% | ≈-940.2% | -270.9% | Débil | |
| EBITDA Margin (Margen EBITDA) | -271.9%promedio 5A ≈-940.2% | ≈-940.2% | -270.9% | Débil | |
| Margen antes de impuestos (TTM) | -1091.8%promedio 5A ≈-2100.9% | ≈-2100.9% | -673.1% | Débil | |
| Margen de Beneficio Neto (TTM) | -1091.8%promedio 5A ≈-2101.1% | ≈-2101.1% | -673.2% | Débil | |
| ROA (TTM) | -163.5%promedio 5A ≈-94.3% | ≈-94.3% | -32.3% | Débil | |
| ROE (TTM) | -4796.5%promedio 5A ≈-161.2% | ≈-161.2% | -29.6% | Débil | |
| ROIC | -234.3%promedio 5A ≈-247.9% | ≈-247.9% | -36.0% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | IRD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Debt / Equity (Deuda / Patrimonio) | 0.1promedio 5A ≈0.0 | ≈0.0 | 0.0 | Baja deuda | |
| Ratio corriente (MRQ) | 12.2promedio 5A ≈9.5 | ≈9.5 | 9.8 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 6.1promedio 5A ≈7.6 | ≈7.6 | 9.1 | Liquidez sólida | |
| Long-Term Debt / Equity (Deuda a Largo Plazo / Patrimonio) | 0.1 | · | 0.0 | Baja deuda |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | IRD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 29.1%promedio 5A ≈1650.1% | ≈1650.1% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -29.1% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | IRD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.3promedio 5A ≈0.4 | ≈0.4 | 0.3 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 5.1promedio 5A ≈22.1 | ≈22.1 | 6.5 | Por debajo del promedio | |
| Revenue / Employee (Ingresos / Empleado) | ≈$525.8K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-93.7%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 11, 2026 | $-0.08 | $-0.16 | 49.5% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.75 | $-0.14 | -421.2% |
| 31 de diciembre de 2025 | $-0.29 | $-0.12 | -146.8% | |
| 30 de septiembre de 2025 | $-0.25 | $-0.13 | -90.4% | |
| 30 de junio de 2025 | $-0.12 | $-0.21 | 42.1% | |
| 31 de marzo de 2025 | $-0.24 | $-0.25 | 5.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $11M | $19M | $40M | $589.0K | $0 | · | · | · | · | · | · | |
| R&D Expense | · | · | · | · | · | · | $5M | $13M | $11M | $10M | $12M | $7M | |
| SG&A Expense | $22M | $18M | $12M | $7M | $8M | $3M | $2M | $7M | $7M | $6M | $6M | $6M | |
| Operating Expenses | $53M | $73M | $30M | $22M | $23M | $20M | $4M | $21M | $17M | $16M | $18M | $13M | |
| Operating Income | $-39M | $-62M | $-11M | $18M | $-23M | $-20M | $-4M | $-21M | $-17M | $-16M | $-18M | $-13M | |
| Interest Expense | · | · | $0 | $9.0K | $2.0K | $7M | $1M | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $313.7K | $254.3K | $207.0K | $118.6K | $103.3K | $133.9K | |
| Other Non-op | $2M | $4M | $2M | $-14.0K | $-157.0K | $9.0K | $-68.0K | $6M | $-8M | $7M | $4M | $-5M | |
| Pretax Income | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | · | · | · | · | · | |
| Income Tax | $0 | $0 | $12.0K | $315.0K | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | $-14M | $-25M | $-9M | $-14M | $-19M | |
| EPS (Basic) | $-0.80 | $-2.15 | $-0.46 | $0.90 | $-3.82 | $-5.28 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 | $-5.28 | · | · | · | · | · | · | |
| Shares (Basic) | 62,221,901 | 26,715,526 | 21,589,821 | 19,931,080 | 14,852,745 | 4,661,110 | · | · | · | · | · | · | |
| Shares (Diluted) | 62,221,901 | 26,715,526 | 21,589,821 | 20,597,212 | 14,852,745 | 4,661,110 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-62M | $-11M | $18M | $-23M | $-20M | · | $-21M | $-17M | $-16M | $-18M | $-13M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45M | $30M | $51M | $43M | $25M | · | $12M | $9M | $9M | $12M | $10M | $10M | |
| Short-term Investments | $0 | $2.0K | $15.0K | $49.0K | $219.0K | $0 | $3M | $6M | $18M | $9M | $13M | $23M | |
| Receivables | $2M | $4M | $926.0K | $1M | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $515.0K | $1M | $1M | $1M | $1M | $149.0K | $1M | $1M | $608.5K | $1M | $731.0K | |
| Other Current Assets | · | · | $102.0K | $80.0K | $71.0K | $26.0K | $5.0K | $555.4K | $510.6K | $429.0K | $720.6K | $361.2K | |
| Current Assets | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $33M | |
| PP&E (Net) | $199.0K | $252.0K | $0 | $6.0K | $10.0K | $14.0K | $22.0K | $112.5K | $121.5K | $88.7K | $112.9K | $78.1K | |
| PP&E (Gross) | · | · | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $821.6K | $833.3K | $758.1K | $749.5K | $687.2K | |
| Accum. Depreciation | · | · | $25.0K | $19.0K | $15.0K | $11.0K | $3.0K | $709.1K | $711.8K | $669.5K | $636.6K | $609.1K | |
| Total Assets | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $34M | |
| Accounts Payable | $3M | $3M | $2M | $1M | $2M | $1M | $342.0K | $3M | $3M | $2M | $3M | $2M | |
| Accrued Liabilities | $4M | $8M | $2M | $2M | $2M | $2M | $621.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $0 | $538.0K | $0 | · | · | · | · | · | · | |
| Current Liabilities | $8M | $11M | $4M | $3M | $4M | $3M | $9M | $3M | · | · | · | · | |
| Capital Leases | · | · | · | · | · | · | $63.6K | · | · | · | · | · | |
| Total Liabilities | $35M | $11M | $4M | $3M | $4M | $31M | $9M | $5M | $12M | $4M | $6M | $7M | |
| Total Debt | $1M | · | · | $0 | $538.0K | · | · | · | · | · | · | · | |
| Common Stock | $7.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | $0 | $312 | $3.2K | $2.4K | $19.7K | $17.8K | |
| Paid-in Capital | $204M | $146M | $131M | $118M | $112M | $19M | $495.0K | · | · | · | · | · | |
| Retained Earnings | $-189M | $-139M | $-81M | $-71M | $-89M | $-33M | $-8M | $-155M | $-140M | $-115M | $-106M | $-91M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $128.4K | |
| AOCI | · | · | · | · | · | · | $2.1K | $-17.8K | $-56.9K | $-6.1K | $-18.0K | $-33.6K | |
| Stockholders' Equity | $15M | $7M | $50M | $46M | $22M | $-13M | $-8M | $-2M | $17M | $17M | $19M | $27M | |
| Liabilities + Equity | $50M | $37M | $54M | $49M | $26M | $18M | $2M | $16M | $28M | $21M | $25M | $34M | |
| Shares Outstanding | 69,894,507 | 31,574,657 | 23,977,491 | 20,861,315 | 18,845,828 | 10,882,495 | 2,852,485 | 3,122,843 | 2,639,319 | 23,736,878 | 19,741,378 | 17,836,652 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $41.0K | $48.2K | $42.4K | $32.9K | $27.5K | $28.3K | |
| Stock-based Comp | $3M | $3M | $4M | $2M | $2M | $2M | $308.0K | $1M | $1M | $1M | $1M | $608.8K | |
| Operating Cash Flow | $-35M | $-26M | $-1M | $14M | $-19M | $-7M | $-4M | $-19M | $-15M | $-13M | $-17M | $-11M | |
| CapEx | · | · | · | · | · | $0 | $25.0K | · | · | · | · | · | |
| Investing Cash Flow | $0 | $1M | $0 | $0 | $-100.0K | $539.0K | $-25.0K | $12M | $-9M | · | · | · | |
| Stock Issued | $6M | $4M | $9M | $4M | $28M | $0 | $8M | $7M | $17M | · | $1M | · | |
| Net Stock Activity | $6M | $4M | $9M | $4M | $28M | · | · | $7M | · | · | · | · | |
| Financing Cash Flow | $50M | $4M | $9M | $4M | $28M | $21M | $5M | $7M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-154.9K | $-3M | $1M | $373.2K | $-9M | |
| Taxes Paid | $0 | $0 | $344.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-7M | · | · | · | · | · | · | |
| Levered FCF | · | · | · | · | · | $-14M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% | · | · | · | · | · | · | · | |
| Net Margin | -349.3% | -523.4% | -52.4% | 44.9% | -9625.3% | · | · | · | · | · | · | · | |
| Pretax Margin | -349.3% | -523.4% | -52.4% | 45.7% | -9625.3% | · | · | · | · | · | · | · | |
| EBITDA Margin | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% | · | · | · | · | · | · | · | |
| ROA | -113.9% | -126.7% | -19.4% | 47.7% | -259.1% | -253.0% | · | -64.8% | -102.6% | -40.6% | -49.3% | -69.8% | |
| ROE | -302.2% | -280.5% | -19.9% | 61.6% | -265.0% | 215.2% | · | -169.3% | -149.6% | -51.9% | -63.4% | -94.5% | |
| ROIC | -234.3% | -923.2% | -21.2% | 38.7% | -99.8% | 148.3% | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.4 | 3.2 | 13.3 | 17.8 | 6.8 | 5.5 | · | · | · | · | · | · | |
| Quick Ratio | 6.1 | 3.0 | 12.7 | 16.0 | 0.1 | · | · | · | · | · | · | · | |
| Debt / Equity | 0.1 | · | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 2025.1 | -11352.5 | -2.9 | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.4 | 1.1 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 5.1 | 4.9 | 17.1 | 61.4 | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.22 | $0.21 | $2.08 | $2.22 | $1.18 | $-1.24 | · | $0.28 | $0.53 | $0.07 | $0.10 | $0.15 | |
| Revenue / Share | $0.23 | $0.41 | $0.88 | $1.93 | $0.04 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.57 | $-0.96 | $-0.05 | $0.69 | $-1.30 | · | · | · | · | · | · | · | |
| Cash / Share | $0.65 | $0.96 | $2.11 | $2.04 | · | · | · | $0.23 | $0.28 | $0.05 | $0.05 | $0.06 | |
| EPS (TTM) | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 | $-5.28 | $-0.25 | $-0.25 | $-1.04 | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 29.1% | -42.3% | -52.2% | 6665.7% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -29.1% | 165.2% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14M | $11M | $19M | $40M | $589.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-50M | $-58M | $-10M | $18M | $-57M | $-25M | $-6M | $-14M | $-25M | $-9M | $-14M | $-19M | |
| Market Cap | $140M | $38M | $72M | $74M | $70M | $71M | · | $1.68B | $3.08B | $15.95B | $34.11B | $59.89B | |
| Enterprise Value | $97M | · | · | $31M | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -0.6 | -6.5 | 4.1 | -1.0 | -1.2 | -30.6 | -178.6 | -93.2 | · | · | · | |
| P/S | 9.9 | 3.4 | 3.8 | 1.8 | 119.3 | · | · | · | · | · | · | · | |
| P/B | 9.2 | 5.6 | 1.4 | 1.6 | 3.2 | -5.2 | · | 158.6 | 183.4 | 935.1 | 1816.9 | 2253.3 | |
| P / Tangible Book | 9.2 | 5.6 | 1.4 | 1.6 | 3.2 | · | · | · | · | · | · | · | |
| P / Cash Flow | -4.0 | -1.5 | -64.9 | 5.1 | -3.6 | -10.4 | · | -88.9 | -199.5 | -1205.9 | -1966.0 | -5424.5 | |
| P / FCF | · | · | · | · | · | -10.4 | · | · | · | · | · | · | |
| EV / EBITDA | -2.5 | · | · | 1.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.8 | · | · | 0.8 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.8% | -180.7% | -15.3% | 24.6% | -102.4% | -81.4% | -3.3% | -0.56% | -1.1% | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $755.0K | $2M | $4M | $3M | $3M | $4M | $4M | $4M | $1M | $2M | $2M | $12M | $4M | $2M | $40M | $0 | |
| SG&A Expense | $6M | $6M | $5M | $5M | $6M | $6M | $7M | $3M | $3M | $5M | $3M | $2M | $4M | $2M | $2M | $2M | |
| Operating Expenses | $17M | $17M | $15M | $11M | $12M | $14M | $42M | $12M | $9M | $9M | $7M | $6M | $9M | $8M | $6M | $5M | |
| Operating Income | $-16M | $-14M | $-11M | $-8M | $-9M | $-10M | $-38M | $-8M | $-8M | $-8M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Other Non-op | $2M | $844.0K | $703.0K | $450.0K | $534.0K | $302.0K | $3M | $483.0K | $563.0K | $602.0K | $613.0K | $456.0K | $428.0K | $340.0K | $46.0K | $7.0K | |
| Pretax Income | $-8M | $-66M | $-17M | $-17M | $-7M | $-8M | $-35M | $-8M | $-8M | $-7M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-2.0K | $14.0K | $0 | $0 | $315.0K | $0 | |
| Net Income | $-8M | $-66M | $-17M | $-17M | $-7M | $-8M | $-35M | $-8M | $-8M | $-7M | $-5M | $6M | $-5M | $-6M | $34M | $-5M | |
| EPS (Basic) | $-0.08 | $-0.75 | $-0.19 | $-0.25 | $-0.12 | $-0.24 | $-1.27 | $-0.29 | $-0.30 | $-0.29 | $-0.20 | $0.26 | $-0.24 | $-0.28 | $1.72 | $-0.22 | |
| EPS (Diluted) | $-0.14 | $-0.75 | $-0.19 | $-0.25 | $-0.12 | $-0.24 | $-1.27 | $-0.29 | $-0.30 | $-0.29 | $-0.19 | $0.25 | $-0.24 | $-0.28 | $1.69 | $-0.22 | |
| Shares (Basic) | 95,483,280 | 86,891,352 | · | 70,636,887 | 63,376,392 | 33,884,920 | · | 26,145,080 | 25,827,265 | 24,520,475 | · | 21,446,648 | 20,959,807 | 20,939,607 | · | 20,498,229 | |
| Shares (Diluted) | 111,384,011 | 86,891,352 | · | 70,636,887 | 63,376,392 | 33,884,920 | · | 26,145,080 | 25,827,265 | 24,520,475 | · | 22,405,995 | 20,959,807 | 20,939,607 | · | 20,498,229 | |
| EBITDA | $-16M | $-14M | · | $-8M | $-9M | $-10M | · | $-8M | $-8M | $-8M | · | $6M | $-5M | $-6M | · | $-5M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $60M | $45M | $31M | $32M | $42M | $30M | $37M | $41M | $47M | $51M | $42M | $40M | $39M | $43M | $14M | |
| Short-term Investments | · | · | $0 | $0 | $0 | $1.0K | $2.0K | $3.0K | $5.0K | $5.0K | $15.0K | $11.0K | $22.0K | $22.0K | $49.0K | $101.0K | |
| Receivables | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $2M | $1M | $2M | $926.0K | $10M | $135.0K | $3M | $1M | · | |
| Prepaid Expense | $2M | $4M | $2M | $815.0K | $1M | $1M | $515.0K | $429.0K | $1M | $2M | $1M | $484.0K | $732.0K | $1M | $1M | $605.0K | |
| Other Current Assets | · | · | · | · | · | · | · | $86.0K | $87.0K | $89.0K | · | $51.0K | $45.0K | $78.0K | $80.0K | $61.0K | |
| Current Assets | $93M | $67M | $50M | $36M | $38M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| PP&E (Net) | $172.0K | $186.0K | $199.0K | $212.0K | $226.0K | $239.0K | $252.0K | $0 | $0 | $0 | $0 | $3.0K | $4.0K | $5.0K | $6.0K | $7.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $25.0K | $25.0K | $25.0K | · | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | $25.0K | $25.0K | $25.0K | · | $22.0K | $21.0K | $20.0K | $19.0K | $18.0K | |
| Total Assets | $93M | $67M | $50M | $36M | $39M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| Accounts Payable | $2M | $4M | $3M | $2M | $1M | $2M | $3M | $844.0K | $634.0K | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Accrued Liabilities | · | · | $4M | · | · | · | $8M | $5M | $3M | $4M | $2M | $2M | $3M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $8M | $9M | $8M | $29M | $20M | $24M | $11M | $6M | $4M | $6M | $4M | $4M | $6M | $4M | $3M | $3M | |
| Total Liabilities | $106M | $88M | $35M | $30M | $21M | $24M | $11M | $6M | $4M | $6M | $4M | $4M | $6M | $4M | $3M | $3M | |
| Long-term Debt | $35M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $8.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $249M | $208M | $204M | $178M | $172M | $152M | $146M | $138M | $137M | $135M | $131M | $127M | $120M | $119M | $118M | $117M | |
| Retained Earnings | $-262M | $-254M | $-189M | $-172M | $-155M | $-147M | $-139M | $-104M | $-96M | $-89M | $-81M | $-77M | $-82M | $-77M | $-71M | $-105M | |
| Stockholders' Equity | $-13M | $-46M | $15M | $6M | $17M | $5M | $7M | $34M | $41M | $46M | $50M | $50M | $38M | $41M | $46M | $12M | |
| Liabilities + Equity | $93M | $67M | $50M | $36M | $39M | $48M | $37M | $40M | $45M | $52M | $54M | $54M | $43M | $45M | $49M | $15M | |
| Shares Outstanding | 82,647,946 | 71,402,472 | 69,894,507 | 64,544,096 | 59,908,055 | 45,483,823 | 31,574,657 | 26,198,444 | 25,979,038 | 25,085,592 | 23,977,491 | 22,610,131 | 20,985,784 | 20,947,830 | 20,861,315 | 20,801,506 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $774.0K | $816.0K | $896.0K | $913.0K | $795.0K | $776.0K | $806.0K | $985.0K | $711.0K | $573.0K | $1M | $804.0K | $424.0K | $493.0K | |
| Operating Cash Flow | $-12M | $-13M | $-10M | $-6M | $-10M | $-9M | $-7M | $-5M | $-7M | $-6M | $5M | $-3M | $989.0K | $-4M | $29M | $-4M | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | $0 | $2M | $179.0K | $5M | $0 | $409.0K | $0 | $456.0K | $2M | $2M | $4M | $5M | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | $409.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $41M | $28M | $24M | $5M | $906.0K | $20M | $-83.0K | $353.0K | $2M | $2M | $4M | $5M | $0 | $0 | $-12.0K | $1M | |
| Net Change in Cash | $29M | $15M | · | · | $-9M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $26.0K | $318.0K | $0 | $0 | $0 | $0 |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2182.8% | -665.9% | · | -269.9% | -309.0% | -227.2% | · | -207.1% | -748.9% | -450.5% | · | 53.5% | -146.7% | -350.5% | · | · | |
| Net Margin | -1072.6% | -3038.2% | · | -566.9% | -257.5% | -187.5% | · | -194.6% | -698.3% | -415.3% | · | 46.6% | -135.0% | -331.1% | · | · | |
| Pretax Margin | -1072.6% | -3038.2% | · | -566.9% | -257.5% | -187.5% | · | -194.6% | -698.3% | -415.3% | · | 46.7% | -135.0% | -331.1% | · | · | |
| EBITDA Margin | -2182.8% | -665.9% | · | -269.9% | -309.0% | -227.2% | · | -207.1% | -748.9% | -450.5% | · | 53.5% | -146.7% | -350.5% | · | · | |
| ROA | -12.3% | -114.0% | · | -45.6% | -17.8% | -16.4% | · | -15.9% | -17.6% | -14.6% | · | 16.2% | -16.2% | -17.6% | · | -24.0% | |
| ROE | -360.9% | 321.5% | · | -86.7% | -25.5% | -32.0% | · | -17.8% | -19.8% | -16.3% | · | 17.9% | -19.0% | -19.8% | · | -27.9% | |
| ROIC | 126.9% | 32.2% | · | -118.1% | -48.2% | -195.7% | · | -23.4% | -20.5% | -16.7% | · | 12.7% | -14.3% | -14.9% | · | -38.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.2 | 7.1 | · | 1.2 | 1.9 | 2.0 | · | 6.6 | 10.7 | 9.0 | · | 13.9 | 7.5 | 10.9 | · | 5.4 | |
| Quick Ratio | 11.8 | 6.6 | · | 1.2 | 1.8 | 1.9 | · | 6.3 | 10.2 | 8.5 | · | 13.4 | 7.0 | 10.1 | · | 5.2 | |
| Debt / Equity | · | -0.0 | · | 0.2 | 0.1 | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| LT Debt / Equity | · | -0.0 | · | 0.2 | 0.1 | · | · | · | · | · | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.3 | 0.1 | 0.1 | · | 0.0 | |
| Receivables Turnover | 0.3 | 0.9 | · | 1.3 | 1.2 | 1.7 | · | 0.6 | 1.5 | 0.7 | · | 2.4 | 39.7 | 1.2 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.16 | $-0.64 | · | $0.09 | $0.29 | $0.11 | · | $1.31 | $1.56 | $1.84 | · | $2.22 | $1.80 | $1.97 | · | $0.57 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.04 | $0.05 | $0.13 | · | $0.15 | $0.04 | $0.07 | · | $0.53 | $0.18 | $0.08 | · | $0.00 | |
| Cash Flow / Share | · | $-0.15 | · | · | · | $-0.27 | · | · | · | $-0.23 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $1.07 | $0.84 | · | $0.48 | $0.54 | $0.92 | · | $1.40 | $1.59 | $1.88 | · | $1.87 | $1.91 | $1.86 | · | $0.67 | |
| EPS (TTM) | $-1.33 | $-1.31 | · | $-1.88 | $-1.92 | $-2.10 | · | $-1.07 | $-0.53 | $-0.47 | · | $1.42 | $0.95 | $0.94 | · | $-0.30 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $12M | · | $15M | $15M | $14M | · | $8M | $16M | $19M | · | $57M | $45M | $42M | · | $0 | |
| Net Income TTM | $-108M | $-107M | · | $-68M | $-58M | $-59M | · | $-27M | $-14M | $-11M | · | $29M | $19M | $19M | · | $-22M | |
| Market Cap | $340M | $325M | · | $106M | $56M | $45M | · | $34M | $40M | $50M | · | $76M | $91M | $79M | · | $42M | |
| Enterprise Value | · | $266M | · | $77M | $25M | · | · | · | · | · | · | · | · | · | · | $28M | |
| P/E | -3.1 | -3.5 | · | -0.9 | -0.5 | -0.5 | · | -1.2 | -2.9 | -4.3 | · | 2.4 | 4.6 | 4.0 | · | -6.7 | |
| P/S | 34.5 | 27.1 | · | 7.3 | 3.7 | 3.3 | · | 4.1 | 2.4 | 2.7 | · | 1.3 | 2.0 | 1.9 | · | · | |
| P/B | -26.2 | -7.1 | · | 17.8 | 3.2 | 8.8 | · | 1.0 | 1.0 | 1.1 | · | 1.5 | 2.4 | 1.9 | · | 3.5 | |
| P / Tangible Book | · | · | · | 17.8 | 3.2 | 8.8 | · | 1.0 | 1.0 | 1.1 | · | 1.5 | 2.4 | 1.9 | · | 3.5 | |
| P / Cash Flow | · | -25.5 | · | · | · | -5.0 | · | · | · | -8.8 | · | · | · | -21.5 | · | · | |
| EV / Revenue | · | 22.2 | · | 5.2 | 1.6 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -32.4% | -28.8% | · | -113.9% | -204.3% | -214.3% | · | -81.7% | -34.6% | -23.4% | · | 42.4% | 21.9% | 25.1% | · | -14.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $14M | $11M | $19M | $40M | $589.0K |
| Margen Operativo % | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% |
| Beneficio neto | $-50M | $-58M | $-10M | $18M | $-57M |
| EPS Diluido | $-0.80 | $-2.15 | $-0.46 | $0.87 | $-3.82 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.1 | · | · | 0.0 | 0.0 |
| Ratio corriente | 6.4 | 3.2 | 13.3 | 17.8 | 6.8 |
| Ratio Rápido | 6.1 | 3.0 | 12.7 | 16.0 | 0.1 |
No hay datos para este estado
Aún no hay suficientes datos fundamentales para generar este estado.
Propietarios institucionales (13F) 107 declarantes · $241.0M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
107
Valor en tenencia
$241.0M
Nuevas posiciones
39
Posiciones cerradas
14
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 39 (+12 vs trimestre anterior) | 14 (+8 vs trimestre anterior) | 34 (+17 vs trimestre anterior) | 13 (-2 vs trimestre anterior) | +13.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Caligan Partners LP | $24 976 815 | 6 077 084 | 10,36% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $24 782 375 | 6 029 775 | 10,28% | Acciones |
| BIOS Capital Management, LP | $15 138 893 | 3 683 429 | 6,28% | Acciones |
| BlackRock, Inc. | $12 808 762 | 3 116 487 | 5,31% | Acciones |
| Balyasny Asset Management L.P. | $12 691 129 | 3 087 866 | 5,27% | Acciones |
| Nantahala Capital Management, LLC | $12 582 185 | 3 061 359 | 5,22% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $12 160 187 | 2 958 683 | 5,05% | Acciones |
| Boxer Capital Management, LLC | $11 569 650 | 2 815 000 | 4,80% | Acciones |
| Trails Edge Capital Partners, LP | $11 276 434 | 2 743 658 | 4,68% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $9 461 635 | 2 302 101 | 3,93% | Acciones |
| GREAT POINT PARTNERS LLC | $8 097 469 | 1 970 187 | 3,36% | Acciones |
| MARSHALL WACE, LLP | $7 996 453 | 1 945 609 | 3,32% | Acciones |
| ADAR1 Capital Management, LLC | $7 331 340 | 1 783 781 | 3,04% | Acciones |
| GOLDMAN SACHS GROUP INC | $6 276 912 | 1 527 229 | 2,60% | Acciones |
| Woodline Partners LP | $5 896 670 | 1 434 713 | 2,45% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $5 622 928 | 1 367 712 | 2,33% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $4 888 907 | 1 189 515 | 2,03% | Acciones |
| VANGUARD GROUP INC | $4 669 022 | 2 322 897 | 1,94% | Acciones |
| Opaleye Management Inc. | $4 623 750 | 1 125 000 | 1,92% | Acciones |
| SummitTX Capital, L.P. | $4 140 213 | 1 007 351 | 1,72% | Acciones |
| STATE STREET CORP | $3 247 459 | 790 136 | 1,35% | Acciones |
| Bleichroeder LP | $3 028 421 | 736 842 | 1,26% | Acciones |
| UBS Group AG | $2 810 808 | 683 895 | 1,17% | Acciones |
| CITADEL ADVISORS LLC | $2 735 871 | 665 662 | 1,14% | Acciones |
| MORGAN STANLEY | $1 910 739 | 464 900 | 0,79% | Acciones |
| NORTHERN TRUST CORP | $1 817 253 | 442 154 | 0,75% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 686 641 | 410 375 | 0,70% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 528 715 | 371 950 | 0,63% | Acciones |
| Squarepoint Ops LLC | $1 359 518 | 330 783 | 0,56% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 043 784 | 253 962 | 0,43% | Acciones |
| AWM Investment Company, Inc. | $955 945 | 232 590 | 0,40% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $809 247 | 196 897 | 0,34% | Acciones |
| JANE STREET GROUP, LLC | $776 741 | 188 988 | 0,32% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $678 368 | 165 053 | 0,28% | Acciones |
| Mink Brook Asset Management LLC | $662 553 | 161 205 | 0,27% | Acciones |
| XTX Topco Ltd | $592 230 | 144 095 | 0,25% | Acciones |
| Seven Fleet Capital Management LP | $588 293 | 143 137 | 0,24% | Acciones |
| Creative Planning | $527 584 | 128 366 | 0,22% | Acciones |
| Texas Capital Bank Wealth Management Services Inc | $503 594 | 122 529 | 0,21% | Acciones |
| Bank of New York Mellon Corp | $503 390 | 122 479 | 0,21% | Acciones |
| Stonepine Capital Management, LLC | $413 951 | 100 718 | 0,17% | Acciones |
| Jump Financial, LLC | $389 711 | 94 820 | 0,16% | Acciones |
| Nuveen, LLC | $293 220 | 71 343 | 0,12% | Acciones |
| Palogic Value Management, L.P. | $267 512 | 65 088 | 0,11% | Acciones |
| Aureus Asset Management, LLC | $239 202 | 58 200 | 0,10% | Acciones |
| Regency Capital Management Inc.\DE | $238 380 | 58 000 | 0,10% | Acciones |
| BANK OF AMERICA CORP /DE/ | $226 070 | 55 005 | 0,09% | Acciones |
| DEUTSCHE BANK AG\ | $219 113 | 53 312 | 0,09% | Acciones |
| Invesco Ltd. | $218 779 | 53 231 | 0,09% | Acciones |
| WELLS FARGO & COMPANY/MN | $216 321 | 52 633 | 0,09% | Acciones |
Activistas y propietarios del %+ 5 17 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness, Inc. ×4 presentaciones | 20 de mayo de 2026 | 4,66% | Enmienda | · | SEC |
| Dr. Chang H. Ahn Not Applicable ×3 presentaciones | 9 de octubre de 2013 | · | Presentación inicial | · | SEC |
| Dr. Chang H Ahn Not Applicable ×2 presentaciones | 20 de mayo de 2011 | · | Presentación inicial | · | SEC |
| Rexgene Biotech Co., Ltd. Not Applicable ×3 presentaciones | 30 de septiembre de 2009 | · | Presentación inicial | Inversión pasiva | SEC |
| KT&G Corporation Not Applicable ×2 presentaciones | 26 de diciembre de 2007 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 23 de mayo de 2005 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 21 de enero de 2005 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 21 de enero de 2005 | · | Presentación inicial | M&A / venta | SEC |
| S.S or | 18 de agosto de 2004 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 45 insiders · 17 directivos · 31 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| George Magrath | Chief Executive Officer | 9 de septiembre de 2026 M | 2 048 485 | 0 | 3 | $-204 920 |
| Sooch Mina | President and CEO | 10 de enero de 2023 A | 430 501 | 0 | 0 | $0 |
| Douglas J Swirsky | President and CEO | 29 de enero de 2019 P | 50 000 | 0 | 0 | $0 |
| Peter David Suzdak | Chief Executive Officer | 28 de febrero de 2018 M | 22 250 | 0 | 0 | $0 |
| Robert E. Gagnon | Chief Financial Officer | 3 de septiembre de 2026 S | 556 375 | 0 | 3 | $-190 702 |
| Nirav S. Jhaveri | Chief Financial Officer | 13 de marzo de 2025 A | 194 293 | 0 | 0 | $0 |
| Tae Heum Jeong | Chief Financial Officer | 20 de enero de 2017 A | 505 000 | 0 | 0 | $0 |
| Benjamin R Yerxa | President | 23 de julio de 2026 S | 704 106 | 0 | 2 | $-61 207 |
| Rakesh Soni | President and COO | 12 de enero de 2014 A | · | 0 | 0 | $0 |
| Joseph K Schachle | Chief Operating Officer | 23 de julio de 2026 S | 291 440 | 0 | 3 | $-57 696 |
| Ashwath Jayagopal | Chief Scientific & Dev. Ofc. | 23 de abril de 2026 S | 509 233 | 0 | 2 | $-58 184 |
| Rabourn Amy Zaremba | Head of Fin. Quality Assurance | 23 de abril de 2026 S | 188 671 | 0 | 2 | $-23 289 |
| Bernhard Hoffmann | SVP of Corp. Dev. | 13 de marzo de 2025 A | 185 446 | 0 | 0 | $0 |
| Ronil A. Patel | Chief Business Officer | 10 de enero de 2024 F | 90 714 | 0 | 0 | $0 |
| Lisa Nolan | Chief Business Officer | 28 de febrero de 2019 M | 23 250 | 0 | 0 | $0 |
| Ely Benaim | Chief Medical Officer | 28 de febrero de 2019 M | 4 750 | 0 | 0 | $0 |
| George F Steinfels | Chief Business Officer Sr. VP | 8 de diciembre de 2005 A | · | 0 | 0 | $0 |
| Cam Gallagher | Consejero | 8 de septiembre de 2026 M | 2 800 111 | 2 | 0 | $323 890 |
| Jean Bennett | Consejero | 20 de abril de 2026 A | 259 019 | 0 | 0 | $0 |
| Sean Ainsworth | Consejero | 20 de abril de 2026 A | 321 692 | 0 | 0 | $0 |
| Susan Benton | Consejero | 20 de abril de 2026 A | 243 894 | 0 | 0 | $0 |
| Adrienne L Graves | Consejero | 20 de abril de 2026 A | 127 514 | 0 | 0 | $0 |
| Richard J Rodgers | Consejero | 20 de abril de 2026 A | 343 022 | 0 | 0 | $0 |
| James S J Manuso | Consejero | 20 de abril de 2026 A | 317 318 | 0 | 0 | $0 |
| Jay Pepose | Consejero | 11 de junio de 2024 A | 180 458 | 0 | 0 | $0 |
| Lara Sullivan, M.D. | Consejero | 6 de junio de 2019 A | · | 0 | 0 | $0 |
| Peter C. Brandt | Consejero | 6 de junio de 2019 A | 150 000 | 0 | 0 | $0 |
| Ben Gil Price | Consejero | 6 de junio de 2019 A | 15 000 | 0 | 0 | $0 |
| Charles Beever | Consejero | 6 de junio de 2019 A | 11 000 | 0 | 0 | $0 |
| Kwang Soo Cheong | Consejero | 6 de junio de 2019 A | 3 000 | 0 | 0 | $0 |
| Mark Carthy | Consejero | 11 de abril de 2017 A | · | 0 | 0 | $0 |
| Chang Ho Ahn | Consejero | 10 de abril de 2017 M | 6 010 000 | 0 | 0 | $0 |
| Si Moon Hwang | Consejero | 9 de junio de 2014 A | · | 0 | 0 | $0 |
| David M Mcintosh | Consejero | 9 de junio de 2014 A | 25 990 | 0 | 0 | $0 |
| Richard Kivel | Consejero | 18 de junio de 2012 A | 2 500 | 0 | 0 | $0 |
| Freddie Ann Hoffman | Consejero | 1 de junio de 2009 A | 1 000 | 0 | 0 | $0 |
| Michele Y Kang | Consejero | 1 de junio de 2009 A | 10 000 | 0 | 0 | $0 |
| Young Soon Park | Consejero | 11 de diciembre de 2006 G | 2 040 500 | 0 | 0 | $0 |
| John W Holaday DR | Consejero | 2 de mayo de 2006 A | · | 0 | 0 | $0 |
| Inok Ahn | Consejero | 8 de diciembre de 2005 A | · | 0 | 0 | $0 |
| Jang Han Rhee | Consejero | 13 de mayo de 2005 A | 2 000 000 | 0 | 0 | $0 |
| Suk Hyung Kwon | Consejero | 13 de mayo de 2005 A | 114 255 | 0 | 0 | $0 |
| Frank Ferraro | Consejero | 11 de enero de 2005 S | 0 | 0 | 0 | $0 |
| Rexgene Biotech Co., Ltd. | Propietario del 10% | 24 de diciembre de 2007 A | 5 505 956 | 0 | 0 | $0 |
| Alan R Meyer | · | 19 de noviembre de 2020 P | 487 029 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 10 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,60% | 31 886 SH | 23 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,08% | 182 492 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,02% | 502 884 SH | 11 de septiembre de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 380 383 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 309 583 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 57 702 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 25 597 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 652 278 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 239 388 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 665 SH | 19 de agosto de 2026 | Diario |
IRD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 22 analistas
COMPRA
Objetivo mediano
$13.00
+274,6%
6 27,3%
Compra fuerte
15 68,2%
Compra
1 4,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
17 analistas · 2026-10-24Objetivo medio $13.47 +288,2%
← Por Debajo de Todos los Objetivos
Precio Actual $3.47
Mín$8.00
Media$13.47
Máx$20.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| SRZN | · | · | · | · | · | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
| SCTX | · | · | · | · | · | · |
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026